Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2000
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983298A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
03/08/2000EP0983286A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
03/08/2000EP0983275A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
03/08/2000EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983256A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
03/08/2000EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
03/08/2000EP0983235A2 Leukotriene b 4? derivatives, in particular oximo-ltb 4? antagonists
03/08/2000EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983074A2 Non-myeloablative tolerogenic treatment
03/08/2000EP0835125A4 Cd4-derived peptides that inhibit immune responses
03/08/2000EP0784623B1 Naphthyridine derivatives
03/08/2000EP0696287B1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
03/08/2000EP0671947B1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
03/08/2000EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins
03/08/2000CN1246892A Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
03/08/2000CN1246867A Helicobacter pylori live vaccine
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246800A Infectious bursits vaccine
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246793A Method and compositions for treating allergic asthma and other diseases using descartoethoxyloratadine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246367A Medicine for treating tinea
03/08/2000CN1246359A Phospholipid capsule preparation
03/08/2000CN1050132C Ginkgotide derivatives
03/08/2000CN1050129C Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034134 1-Amino-alkylcyclohexane NMDA receptor antagonists
03/07/2000US6034112 Use of flupirtine the prophylaxis and therapy of diseases associated with an impairment of the hematopoetic cell system
03/07/2000US6034111 Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system
03/07/2000US6034096 Compounds with anti-inflammatory and immunosuppressive activities
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases
03/07/2000US6034056 Cyclic peptides; antiarthritic agents
03/07/2000US6034055 Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033864 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
03/07/2000US6033673 Double mutant enterotoxin for use as an adjuvant
03/07/2000US6033671 Identification of human cytomegalovirus genes involved in down-regulation of MHC class I heavy chain expression
03/07/2000US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
03/07/2000US6033667 Method for detecting the presence of P-selectin
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011160A1 Grip, human adapter protein related to the grb2 family member
03/02/2000WO2000011027A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010597A1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
03/02/2000WO2000010595A2 Medicaments for manipulating t-cell immune response
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010585A1 THE COMBINATION OF MOXA CONE AND THE HOMEOPATHIC SPECIFIC OF THE AGENT CREATING IgE TYPE ALLERGY TO TREAT THE MENTIONED ALLERGIES
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010547A2 New use of taxoid derivatives
03/02/2000WO2000010388A1 Sialidases as mucosal adjuvants
03/02/2000WO1999066879A3 Systemic immune activation method using nucleic acid-lipid complexes
03/02/2000WO1999064059A3 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
03/02/2000WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999055377A9 Polyol-ifn-beta conjugates
03/02/2000WO1999052547A9 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838462A1 Aseptic herbal liquid useful as drink or tincture for poultices
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341191A1 New use of taxoid derivatives
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1172